The chief medical officer in Memorial Sloan Kettering Cancer Center, NY (one of the world most-famous cancer treatment and research institutions), Co-director of Vall d’Hebron Instituto Oncológico (VHIO) in Barcelona, and the Director of the Institute Oncologic Baselga affiliated with Quiron Salud Barcelona Clinic, the President of the European Society for Oncology. He has performed the first researches on the patients with the monoclonal antibodies (Erbitux y Herceptin) for the receptor of epidermal growth factor, the results of which have improved the life expectancy of thousands of patients around the world.[/vc_column_text][/vc_column][/vc_row]
Оncólogo
Brief info
Президент Европейского общества медицинской онкологии.